UnitedHealth Group Incorporated $UNH Position Boosted by QRG Capital Management Inc.

QRG Capital Management Inc. grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 18.2% in the second quarter, HoldingsChannel reports. The fund owned 135,858 shares of the healthcare conglomerate’s stock after buying an additional 20,916 shares during the period. QRG Capital Management Inc.’s holdings in UnitedHealth Group were worth $56,467,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. PBCay One RSC Ltd bought a new stake in UnitedHealth Group during the first quarter worth approximately $14,343,000. Lee Johnson Capital Management LLC acquired a new position in UnitedHealth Group during the second quarter worth about $6,180,000. Kinsale Capital Group Inc. lifted its holdings in UnitedHealth Group by 13.4% in the 2nd quarter. Kinsale Capital Group Inc. now owns 38,510 shares of the healthcare conglomerate’s stock valued at $16,006,000 after acquiring an additional 4,557 shares during the last quarter. Vaughan David Investments LLC IL lifted its stake in UnitedHealth Group by 2.7% during the fourth quarter. Vaughan David Investments LLC IL now owns 150,773 shares of the healthcare conglomerate’s stock valued at $49,772,000 after purchasing an additional 3,934 shares during the last quarter. Finally, Fideuram Intesa Sanpaolo Private Banking S.P.A. lifted its position in shares of UnitedHealth Group by 1,287.2% during the 1st quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. now owns 60,022 shares of the healthcare conglomerate’s stock valued at $16,241,000 after acquiring an additional 55,695 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on UNH shares. Wall Street Zen raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. BMO Capital Markets set a $512.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, July 21st. TD Cowen raised their target price on UnitedHealth Group from $337.00 to $430.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Barclays upped their price target on UnitedHealth Group from $429.00 to $441.00 and gave the company an “overweight” rating in a research report on Monday, July 20th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, June 11th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $456.56.

UnitedHealth Group Stock Down 0.6%

UNH stock traded down $2.19 during trading hours on Wednesday, hitting $370.76. The company’s stock had a trading volume of 3,859,184 shares, compared to its average volume of 7,514,413. The stock has a 50 day moving average price of $401.67 and a two-hundred day moving average price of $372.70. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62. The company has a market capitalization of $332.79 billion, a PE ratio of 23.86, a price-to-earnings-growth ratio of 1.42 and a beta of 0.61. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.94 by $1.44. The business had revenue of $112.03 billion during the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. UnitedHealth Group’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 19.85 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were issued a dividend of $2.32 per share. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 59.72%.

Insiders Place Their Bets

In related news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.19% of the company’s stock.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth’s turnaround plan is gaining credibility. Management previously indicated it would reduce membership in some areas to rebuild margins, and the strategy has helped drive a roughly 40% stock recovery since late March. Did UnitedHealth Name The Fix Before Its Stock Ran?
• Positive Sentiment: Second-quarter operating earnings rose sharply, supported by margin improvement at UnitedHealthcare and Optum Health, cost controls, contract resets and technology efficiencies. Management raised its full-year adjusted EPS outlook to $19.50–$20.00, reinforcing expectations for earnings growth into 2027 and beyond. UnitedHealth: Margin Recovery And Earnings Growth Support Further Upside
• Neutral Sentiment: UnitedHealth’s latest quarter exceeded expectations, with $6.38 in EPS and $112.03 billion in revenue. However, revenue growth was only about 0.4% year over year, meaning future upside depends heavily on sustaining margin gains.
• Negative Sentiment: Analyst commentary favors Molina Healthcare’s Medicaid recovery, Medicare dual-eligible growth and contract wins over UnitedHealth’s broader but less focused recovery story. This relative preference may be limiting enthusiasm for UNH. UNH vs. MOH: Which Managed Care Stock Looks More Attractive?
• Negative Sentiment: The main risk is medical-cost inflation: with sales nearly stagnant, higher-than-expected claims could quickly erode the margin recovery and challenge UnitedHealth’s $19.50–$20.00 EPS guidance. Can UNH Stock Keep Growing Earnings While Its Sales Stall?

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.

UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.